Botulinum toxin to avoid component separation in midline large hernias

Area of Science:

• Abdominal surgery
• Hernia repair techniques
• Minimally invasive surgery

Background:

• Large midline incisional hernias present significant surgical challenges.
• Traditional repair methods like component separation can lead to complications.
• Evaluating novel approaches is crucial for improving patient outcomes.

Purpose of the Study:

• To compare preoperative botulinum toxin with anterior component separation for large midline incisional hernias.
• To assess surgical site occurrences, fascial closure rates, hospital stay, and recurrence.
• To determine the efficacy of botulinum toxin in facilitating Rives repair.

Main Methods:

• A prospective comparative study of 80 patients with large midline incisional hernias (transverse diameter 11-17 cm).
• Two groups: 40 patients received preoperative botulinum toxin before Rives repair, 40 underwent component separation.
• Outcomes including surgical site complications and recurrence were prospectively analyzed.

Main Results:

• Complete fascial closure was achieved in all patients receiving botulinum toxin.
• Surgical site complications, particularly skin necrosis, were significantly higher in the component separation group (12.5%, P=.020).
• Hernia recurrence occurred in 8.9% of the component separation group, with none in the botulinum toxin group.

Conclusions:

• Preoperative botulinum toxin enables successful downstaging to Rives repair for large midline incisional hernias.
• This method minimizes complications associated with anterior component separation.
• Botulinum toxin is a valuable adjunct for complex hernia repairs.